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Abstract
This paper deals with the effects of the medicinal agent xymedon and its six new two-fragment
analogs containing fragments of xymedon and biogenic acids, in the stimulation of rats' physical
performance in the test of forced swimming with weights. It was noted that single and multiple
injection (for 21 day) of the tested substances did not have any statistically significant act-
protective effect.  The most  pronounced effect  was observed for  act-protective L-ascorbate
compound 1-(2-hydroxyethyl) -4.6-dimethyl-1.2-dihydropyrimidine-2-one (20 mg/kg) in the 11-
day intraperitoneal injection. The effect of the swimming time stimulation for rats, on day 14 of
the experiment, was 440% higher relative to the control group. Compound is a conjugate,
comprising the fragments of xymedon and ascorbic acid. With the injection of the compound for
11  days,  in  a  debilitating  physical  exertion  conditions,  no  influence  on  the  processes  of
leucopoiesis was noticed. Increase in the number of erythrocytes and hemoglobin level in blood
indicate the stimulation of erythropoiesis. Revealed biochemical signs indicating improvement in
the exercise tolerance upon the injection of the substance to animals and its anti-catabolic
action. The absence of cardio- and hepatotoxic action of the substance was disclosed.
Keywords
Act-protection, Environmental pharmacology, Generalized linear models, Pyrimidine derivatives,
Xymedon
